Skip to main content
Top
Published in: Arthritis Research & Therapy 1/2012

Open Access 01-12-2012 | Poster presentation

Peripheral tolerance induced by apoptotic cells and PD-1+ CD8 T cells

Authors: Hirotaka Kazama, Tomonori Iyoda, Satoko Yokoyama, Kayo Inaba, Thomas A Ferguson, Shin Yonehara

Published in: Arthritis Research & Therapy | Special Issue 1/2012

Login to get access

Excerpt

Self tolerization in peripheral is critical to prevent autoimmune diseases including arthritis and here we focus on the role of PD-1 in tolerance induction against the antigen associated with apoptotic cellsdelivered intravenously (i.v.). We accessed delayed type hypersensitivity (DTH) reaction against hapten (TNP) as antigen specific immune response, in which the injection of TNP-apoptotic cells i.v. suppressed DTH in wild type mice but we found not in PD-1 KO mice (Figure 1). Adaptive transfer of CD8 T cells into PD-1 KO mouse from wild type mice tolerated with TNP-apoptotic cells suppresses DTH. This result shows PD-1 functions on CD8 T cells for immune suppression. Additionally we neutralized the PD-1 with antibody to determine the phase when PD-1 functions for immune tolerance by apoptotic cells, and identified PD-1 functions particularly at the initial phase of antigen specific immune response. We are further studying the mechanism of suppressive role of PD-1+ CD8 T cells that should be activated with apoptotic cells.
Metadata
Title
Peripheral tolerance induced by apoptotic cells and PD-1+ CD8 T cells
Authors
Hirotaka Kazama
Tomonori Iyoda
Satoko Yokoyama
Kayo Inaba
Thomas A Ferguson
Shin Yonehara
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Arthritis Research & Therapy / Issue Special Issue 1/2012
Electronic ISSN: 1478-6362
DOI
https://doi.org/10.1186/ar3635

Other articles of this Special Issue 1/2012

Arthritis Research & Therapy 1/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.